Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-18-000116
Filing Date
2018-02-13
Accepted
2018-02-13 17:04:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 cumberland13ga1.htm SC 13G/A 57561
  Complete submission text file 0000935836-18-000116.txt   59034
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 18604620
SIC: 2834 Pharmaceutical Preparations

Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541.647.5664
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A